Rising awareness of personalized medicine is contributing to the expansion of the South and Central America Cancer Targeted Therapy Market and supporting more individualized treatment strategies. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of 11.6%...

The adoption of precision medicine is accelerating the Middle East Cancer Targeted Therapy Market by improving the focus on individualized cancer treatment approaches. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9% from 2025 to 2031. Cancer targeted therapy...

The Africa Cancer Targeted Therapy Market is supported by expanding oncology services, improving healthcare infrastructure, and greater investment in cancer care. The Africa Cancer Targeted Therapy Market size is expected to reach US$ 3,477.6 million by 2031 from US$ 1,733.4 million in 2024. The market is estimated to record a CAGR of 10.5% from 2025 to 2031. Targeted therapy...

Multiple Myeloma Therapeutics Market Growing at 6.1% CAGR According to Straits Research, the global Multiple Myeloma Therapeutics Market was valued at USD 23.27 Billion in 2021 and is projected to grow from USD XX Billion in 2022 to USD 39.65 Billion by 2030, reflecting a CAGR of 6.1% over the forecast...